Novel mutant KRAS addiction signature predicts response to the combination of ERBB and MEK inhibitors in lung and pancreatic cancers

Autor: Tyc, Katarzyna M., Kazi, Aslamuzzaman, Ranjan, Alok, Wang, Rui, Sebti, Said M.
Zdroj: In iScience 17 March 2023 26(3)
Databáze: ScienceDirect